Table III.
Multivariate regression analysis in predicting the survival of patients with renal carcinoma.
| Event-free survival | Overall survival | |||
|---|---|---|---|---|
| Variable | HR (95% CI) | P-value | HR (95% CI) | P-value |
| Age | ||||
| <60 | 2.590 (0.624–10.745) | 0.190 | 2.119 (0.461–9.729) | 0.334 |
| ≥60 | ||||
| Sex | ||||
| Female | 0.650 (0.156–2.703) | 0.553 | 0.799 (0.174–3.671) | 0.773 |
| Male | ||||
| TNM stage | ||||
| I | 5.521 (1.321–23.076) | 0.019a | 9.468 (2.052–43.679) | 0.004a |
| II–IV | ||||
| Tumor stage | ||||
| T1-2 | 0.678 (0.259–1.777) | 0.429 | 0.512 (0.184–1.424) | 0.200 |
| T3-4 | ||||
| Nodal status | ||||
| N0 | 1.450 (0.508–4.143) | 0.488 | 1.434 (0.482–4.269) | 0.517 |
| N1 | ||||
| Metastasis | ||||
| M0 | 1.470 (0.723–2.986) | 0.287 | 1.198 (0.548–2.618) | 0.650 |
| M1 | ||||
| Nuclear grade | ||||
| 1–2 | 0.962 (0.668–1.385) | 0.834 | 0.924 (0.632–1.349) | 0.681 |
| 3–4 | ||||
| RSF1 expression status | ||||
| High | 0.176 (0.066–0.472) | 0.001a | 4.023 (1.263–12.820) | 0.019a |
| Low | ||||
P-value was obtained using a χ2 test.
a
P<0.05 is considered to indicate a statistically significant difference (two-sided). HR, hazard ratio; CI, confidence interval; RSF1, remodeling and spacing factor 1; TNM, tumor node metastasis.